Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ReST THERAPEUTICS logo — Recovery from Stress and Trauma

ReST THERAPEUTICS

Recovery from Stress and Trauma

Founded 2020 United States New Haven, United States 8 employees Grant Biotechnology, Pharmaceutical

General Information

Company Name ReST THERAPEUTICS
Founded Year 2020
Location United States New Haven, United States
Employees 8
Industries Biotechnology, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with ReST THERAPEUTICS. To contact ReST THERAPEUTICS, visit rest-therapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ReST THERAPEUTICS compare?

A PDF of ReST THERAPEUTICS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ReST THERAPEUTICS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ReST THERAPEUTICS

ReST Therapeutics is developing transformative therapies for patients with significant unmet needs in Psychiatry and Neurodegeneration. Our lead program, RST-01, will disrupt the existing PTSD treatment paradigm, focusing on early intervention in the aftermath of a traumatic event and a patient-centric clinical strategy. RST-01 targets specific NMDA receptors sub-types, critical to memory consolidation. Pre-clinical testing has shown drastic reductions in fear, anxiety and depression, as well as the restoration of cognitive function. Finally, reduced neuroinflammation in neurodegenerative models paves the way for an extended development portfolio focusing on restoring the quality of lives of those affected by these debilitating diseases.

Business keywords: Pharmaceutical development, PTSD treatment, Neuropsychiatry, Neuroinflammation, Neurodegeneration, Clinical trials, NMDA receptor modulation, Therapeutics, Pre-clinical testing, Cognitive function restoration, Memory consolidation, Seed funding, Non-clinical testing

No funding data available for ReST THERAPEUTICS yet.

ReST THERAPEUTICS Alternatives & Competitors

View All Alternatives
ReST THERAPEUTICS vs
Umecrine Cognition AB
Umecrine Cognition AB Sweden

A novel and safe approach for treating cognitive disorders

Convertible Note
11 employees
Biotechnology, Health Care
ReST THERAPEUTICS vs
Relmada Therapeutics, Inc
Relmada Therapeutics, Inc United States

Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the treatment of...

Post-IPO Equity
32 employees
Biotechnology, Pharmaceutical
ReST THERAPEUTICS vs
Upstream Bio
Upstream Bio United States

Developing treatments for inflammatory diseases

IPO
78 employees
Biotechnology, Health Care
View all alternatives

FAQ About ReST THERAPEUTICS

Recovery from Stress and Trauma
ReST THERAPEUTICS was founded in 2020.
ReST THERAPEUTICS is headquartered in New Haven, United States.
ReST THERAPEUTICS operates in Biotechnology and Pharmaceutical. Its work centres on Pharmaceutical development, PTSD treatment, Neuropsychiatry and Neuroinflammation.
ReST THERAPEUTICS has approximately 8 employees.
Top alternatives and competitors to ReST THERAPEUTICS include Umecrine Cognition AB, Relmada Therapeutics, Inc, Upstream Bio, ASLAN Pharmaceuticals, Skye Bioscience Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ReST THERAPEUTICS and Umecrine Cognition AB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ReST THERAPEUTICS, https://bouncewatch.com/company/rest-therapeutics, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes